GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grown Rogue International Inc (XCNQ:GRIN) » Definitions » Capex-to-Revenue

Grown Rogue International (XCNQ:GRIN) Capex-to-Revenue : 0.08 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Grown Rogue International Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Grown Rogue International's Capital Expenditure for the three months ended in Dec. 2024 was C$-0.67 Mil. Its Revenue for the three months ended in Dec. 2024 was C$8.05 Mil.

Hence, Grown Rogue International's Capex-to-Revenue for the three months ended in Dec. 2024 was 0.08.


Grown Rogue International Capex-to-Revenue Historical Data

The historical data trend for Grown Rogue International's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grown Rogue International Capex-to-Revenue Chart

Grown Rogue International Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Oct19 Oct20 Oct21 Oct22 Oct23 Dec24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.22 0.06 0.06 0.06

Grown Rogue International Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Mar24 Jun24 Sep24 Dec24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.05 0.03 0.11 0.08

Competitive Comparison of Grown Rogue International's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grown Rogue International's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Grown Rogue International's Capex-to-Revenue falls into.


;
;

Grown Rogue International Capex-to-Revenue Calculation

Grown Rogue International's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.478) / 38.491
=0.06

Grown Rogue International's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.671) / 8.052
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grown Rogue International  (XCNQ:GRIN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Grown Rogue International Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Grown Rogue International's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Grown Rogue International Business Description

Traded in Other Exchanges
Address
550 Airport Road, Medford, OR, USA, 97504
Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States.
Executives
Stephen Mark Gledhill Director
Abhilash Patel Director
Lp Bengal Catalyst Fund 10% Security Holder
Jakob Iotte Senior Officer
Adam Michael Barnard August Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
J. Obie Strickler 10% Security Holder, Director, Senior Officer
Sean Kenneth Conacher Director
Tom L. Fortner Senior Officer
Robert John Rigg Senior Officer
Jacques Habra Senior Officer